Digital health and AI tools have skyrocketed since the start of the COVID-19 pandemic. The potential is enormous - yet the long term scalability and sustainability of these innovations remains unknown. As the digital health space propels forward, key questions remain on how we can create an environment where innovators thrive and governmental policies support sustainable business models. In this panel discussion, speakers will reflect on the types of partnerships and structures needed to ensure high-impact products reach those most in need, and tools which improve health outcomes continue to do so well beyond the pandemic.
Moderator: Sarah Des Rosiers
Stakeholder Engagement Lead, Novartis Foundation
Sarah Des Rosiers is a global health professional dedicated to use the power of innovation and partnerships to solve today’s health access challenges. In 2020, Sarah joined the Novartis Foundation to shape the outcome measurement work of its cardiovascular urban health initiatives and to build cardiovascular population health approaches in low-middle income countries that are driven by innovative health and care delivery.
A former management consultant with PwC, she advised major healthcare players (pharma industry and global health organizations) on projects that focused on market access, management improvements and impact evaluation.
Prior to this, she held roles at WHO, UNAIDS and the Clinton Health Access Initiative and built her expertise in program and grant management, focusing on strengthening health systems and increasing access to affordable services and medicines globally. Through all these roles, she worked closely with health authorities and partners in countries like Haiti, Tanzania and Cameroon.
Sarah received an MSc in International Health Policy & Economics (LSE) and an MBA from the University of St. Gallen (HSG), Switzerland. She was born in Canada and lives with her family in Switzerland.